Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Case Western Reserve University / University Hospitals Case Medical Center
mi
from
Cleveland, OH
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Case Western Reserve University / University Hospitals Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
University of Pennsylvania - Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
University of Pennsylvania - Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Texas Oncology - Austin Midtown
mi
from
Austin, TX
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Methodist Cancer Center
mi
from
Houston, TX
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Methodist Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated:  4/18/2018
Northwest Cancer Specialists
mi
from
Vancouver, WA
Safety Study of SGN-CD70A in Cancer Patients
A Phase 1 Trial of SGN-CD70A in Patients With CD70-Positive Malignancies
Status: Enrolling
Updated: 4/18/2018
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated:  4/18/2018
Illinois CancerCare, P.C.
mi
from
Pekin, IL
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated: 4/18/2018
Illinois CancerCare, P.C.
mi
from
Pekin, IL
Click here to add this to my saved trials
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated:  4/18/2018
OSF Radiation Oncology
mi
from
Pekin, IL
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated: 4/18/2018
OSF Radiation Oncology
mi
from
Pekin, IL
Click here to add this to my saved trials
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated:  4/18/2018
Illinois Cancercare, Pc
mi
from
Peoria, IL
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated: 4/18/2018
Illinois Cancercare, Pc
mi
from
Peoria, IL
Click here to add this to my saved trials
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated:  4/18/2018
OSF Radiation Oncology
mi
from
Peoria, IL
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
The Effect of Taxane Chemotherapy on Balance in Breast Cancer Patients
Status: Enrolling
Updated: 4/18/2018
OSF Radiation Oncology
mi
from
Peoria, IL
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
Mayo Clinic
mi
from
Scottsdale, AZ
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
Ashford Cancer Centre
mi
from
Kurralta Park,
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
Ashford Cancer Centre
mi
from
Kurralta Park,
Click here to add this to my saved trials
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated:  4/18/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Study of SBP-101 in Pancreatic Cancer
A Phase 1A/1B Study of SBP-101 in Previously Treated Subjects With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Status: Enrolling
Updated: 4/18/2018
HonorHealth Research Institute
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Wearable Exercise Trackers in Cancer Rehabilitation
Wearable Exercise Trackers in Cancer Rehabilitation
Status: Enrolling
Updated:  4/18/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Wearable Exercise Trackers in Cancer Rehabilitation
Wearable Exercise Trackers in Cancer Rehabilitation
Status: Enrolling
Updated: 4/18/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated:  4/18/2018
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated: 4/18/2018
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated:  4/18/2018
Rocky Mountain Cancer Center
mi
from
Denver, CO
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated: 4/18/2018
Rocky Mountain Cancer Center
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated:  4/18/2018
Research Medical Center - HCA Midwest
mi
from
Kansas City, MO
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)
Status: Enrolling
Updated: 4/18/2018
Research Medical Center - HCA Midwest
mi
from
Kansas City, MO
Click here to add this to my saved trials
Women's Activity and Lifestyle Study in Connecticut
Impact of Exercise on Ovarian Cancer Prognosis
Status: Enrolling
Updated:  4/18/2018
Yale University
mi
from
New Haven, CT
Women's Activity and Lifestyle Study in Connecticut
Impact of Exercise on Ovarian Cancer Prognosis
Status: Enrolling
Updated: 4/18/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Georgia Cancer Center for Excellence at Grady Memorial Hospital
mi
from
Atlanta, GA
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Georgia Cancer Center for Excellence at Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Cancer Institute at St. John's Hospital
mi
from
Springfield, IL
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Cancer Institute at St. John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Parkview Regional Cancer Center at Parkview Health
mi
from
Fort Wayne, IN
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Parkview Regional Cancer Center at Parkview Health
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
St. Agnes Hospital Cancer Center
mi
from
Baltimore, MD
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
St. Agnes Hospital Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Hudner Oncology Center at Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Hudner Oncology Center at Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
Saint Joseph Mercy Cancer Center
mi
from
Ann Arbor, MI
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
Saint Joseph Mercy Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated:  4/19/2018
McGill Cancer Centre at McGill University
mi
from
Montreal,
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Status: Enrolling
Updated: 4/19/2018
McGill Cancer Centre at McGill University
mi
from
Montreal,
Click here to add this to my saved trials
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Status: Enrolling
Updated:  4/19/2018
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection
Status: Enrolling
Updated: 4/19/2018
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
TXA Study in Major Oncologic Surgery
The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery
Status: Enrolling
Updated:  4/19/2018
Spectrum Health Hospitals
mi
from
Grand Rapids, MI
TXA Study in Major Oncologic Surgery
The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery
Status: Enrolling
Updated: 4/19/2018
Spectrum Health Hospitals
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
University of Alabama
mi
from
Birmingham, AL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Childrens National Medical Center
mi
from
Washington,
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Memorial Hospital, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Johns Hopkins Oncology Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital/Dana Farber Cancer Institute
mi
from
Boston, MA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital/Dana Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Beth Israel Med Ctr
mi
from
New York, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Cleveland Clinic
mi
from
Cleveland, OH
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Texas Children's Hospital
mi
from
Houston, TX
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase 1 Dose-Escalation Study of ABT-888 (Veliparib) in Combination With Carboplatin in HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  4/20/2018
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase 1 Dose-Escalation Study of ABT-888 (Veliparib) in Combination With Carboplatin in HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 4/20/2018
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase 1 Dose-Escalation Study of ABT-888 (Veliparib) in Combination With Carboplatin in HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  4/20/2018
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Phase 1 Dose-Escalation Study of ABT-888 (Veliparib) in Combination With Carboplatin in HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 4/20/2018
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials